Liquid Preterm Formula Versus Powdered Human Milk Fortifier in VLBW Infants
Randomized Study of a Liquid High-Calorie Preterm Formula Versus Powdered Human Milk Fortifier in Very-Low Birthweight Infants
1 other identifier
interventional
84
1 country
1
Brief Summary
This study aims to compare the short-term effects on growth and feeding tolerance of a liquid high calorie formula added to human milk versus powdered human milk fortifier in small preterm infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2008
CompletedFirst Posted
Study publicly available on registry
September 26, 2008
CompletedStudy Start
First participant enrolled
October 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2010
CompletedDecember 10, 2013
December 1, 2013
1.4 years
September 24, 2008
December 9, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome will be weight gain in g/kg/d over the observation period. Body weight will be measured daily.
2 - 6 weeks
Secondary Outcomes (1)
Hospital stay and feeding intolerance
2-6 weeks
Study Arms (2)
1
ACTIVE COMPARATORLiquid human milk fortifier
2
ACTIVE COMPARATORPowdered human milk fortifier
Interventions
Liquid pre-term formula 30Kcals/oz. used as human milk fortifier.
Eligibility Criteria
You may qualify if:
- Infants between 500 and 1499 grams of birthweight, receiving mother's milk.
You may not qualify if:
- Infants with major congenital anomalies and previous history of gastrointestinal disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neonatal Intensive Care Unit/Children's Hospital
Oklahoma City, Oklahoma, 73104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Willeitner, M.D.
University of Oklahoma
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2008
First Posted
September 26, 2008
Study Start
October 1, 2008
Primary Completion
March 1, 2010
Study Completion
September 1, 2010
Last Updated
December 10, 2013
Record last verified: 2013-12